{"id":13647,"date":"2019-07-23T08:22:55","date_gmt":"2019-07-23T12:22:55","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13647"},"modified":"2019-07-23T08:22:55","modified_gmt":"2019-07-23T12:22:55","slug":"fda-approves-1st-lyrica-generics","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13647","title":{"rendered":"FDA approves 1st Lyrica generics"},"content":{"rendered":"<p>(By Alia Paavola for Becker&#8217;s Hospital Review)<\/p>\n<p>The FDA\u00a0<a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-generics-lyrica\">has approved<\/a>\u00a0several new generics of Lyrica, a brand-name drug manufactured by Pfizer to treat fibromyalgia, nerve pain and partial onset seizures in patients 17 years of age and older. They are the first FDA-approved generics for the drug.\u00a0 Continue reading <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/fda-approves-1st-lyrica-generics.html\">article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo3.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-7883\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo3.jpg\" alt=\"\" width=\"179\" height=\"181\" \/><\/a><\/p>\n<pre><span style=\"color: #000000; font-family: Calibri;\">Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/span><\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Alia Paavola for Becker&#8217;s Hospital Review) The FDA\u00a0has approved\u00a0several new generics of Lyrica, a brand-name drug manufactured by Pfizer<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,15],"tags":[],"class_list":["post-13647","post","type-post","status-publish","format-standard","hentry","category-fda","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13647"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13647\/revisions"}],"predecessor-version":[{"id":13648,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13647\/revisions\/13648"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}